SākumlapaMEHCQ • OTCMKTS
23andMe Holding Co.
1,15 $
11. apr., 20:10:00 GMT-4 · USD · OTCMKTS · Atruna
AkcijaVērtspapīrs tiek tirgots šeit: ASVGalvenā biroja atrašanās vieta: ASV
Slēgšanas kurss
1,17 $
Dienas diapazons
1,07 $ - 1,18 $
Gada diapazons
0,48 $ - 12,76 $
Tirgus kapitalizāc.
30,85 milj. USD
Vid. apjoms
8,09 milj.
P/E koeficients
-
Ienākumi no dividendēm
-
Galvenā birža
OTCMKTS
Ziņās
Par
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell. Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008. The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Dibināšanas datums
apr. 2006
Tīmekļa vietne
Darbinieki
571
Meklēšana
Notīrīt meklēšanu
Aizvērt meklēšanas lodziņu
Google lietotnes
Galvenā izvēlne